Drug Design and Optimization
In order to combat the increasing number of resistant pathogens, the development of new anti-infective drugs is an important goal for pharmaceutical research. Efficient medications with novel modes-of-action to fight infectious diseases are urgently needed. Below, you may read more about the design, identification and optimisation of new drug candidates. This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS).
Leader
Technology Offers
The following technologies have been developed and patented by the department Drug Design and Optimization:
Biodynamers enhance drug delivery
Innovative Inhibitors of Pseudomonas Pathogenicity
Cystobactamides – novel antibacterials against gram-negative pathogens
Overcoming resistance - Novel inhibitors of virulence factor LasB of Pseudomonas aeruginosa
Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
Further Information
A current overview of the team and further information about the research group can be found on the HIPS page.
News
Bachelor & Master
Are you interested in a bachelor or master thesis? We are looking forward to your request!